stock delisting
T2 Biosystems Receives Nasdaq Delisting Notice
In October, the company regained compliance with the Nasdaq minimum bid price requirement after undergoing a reverse stock split.
Invitae Warned by NYSE of Noncompliance
The firm is in the midst of a restructuring and the NYSE noncompliance notification results from Invitae's common stock closing below $1 per share for 30 consecutive days.
Trinity Biotech Regains Nasdaq Compliance
Nasdaq warned Trinity last month that its closing bid price fell short of a $1 minimum listing requirement and the firm faced possible delisting action.
Trinity Biotech, LumiraDx Receive Nasdaq Delisting Warnings
The notices that the companies are out of compliance with the Nasdaq's listing requirements come as both deal with financial difficulties.
T2 Biosystems Warned by Nasdaq Over Listing Requirement
Nasdaq informed T2 Bio that its shares have failed to meet a minimum $1 per share closing price for 30 consecutive days, which may result in the delisting of the firm's shares.